Tirzepatide 7.5 mg: what it costs
Step 3 of the tirzepatide ladder, around weeks 9-12. 6 providers charge the same here as at the starting dose — the rest may not.
Updated 2026-09-18 · every price checked by hand
How we make money: one company on this page — Coreage Rx — pays us a commission when a reader signs up through our link. It buys them nothing else: not a better score, not a higher place in the table, not the removal of a single criticism. Our scoring method and full disclosure are both public.
7.5 mg is step 3 of 6 on the tirzepatide ladder, reached around weeks 9-12. An intermediate step on the way to the higher doses. Not a target in itself for most people, though some settle here.
Because this is an early rung, the main cost question is not what 7.5 mg costs today but what happens when you reach the higher doses. Programmes that hold one price across the whole ladder are the ones that make that predictable.
What 7.5 mg is for
7.5 mg is a bridge rather than a destination. It exists so that the jump from 5 mg to 10 mg happens in two manageable steps instead of one large one. Most people pass through it; some find it is where the appetite effect finally becomes reliable and stay. Because it sits between the two doses that carry the trial evidence, there is less published data specific to it than either neighbour.
Side effects at this step tend to be milder than the jump to 5 mg, because your system has adjusted.
Where 7.5 mg sits on the ladder
| Step | Dose | Roughly when |
|---|---|---|
| 1 | 2.5 mg | weeks 1-4 |
| 2 | 5 mg | weeks 5-8 |
| 3 | 7.5 mg ← this page | weeks 9-12 |
| 4 | 10 mg | weeks 13-16 |
| 5 | 12.5 mg | weeks 17-20 |
| 6 | 15 mg | weeks 21+ |
What 7.5 mg costs
6 of the providers we track hold a single price at every dose, so 7.5 mg costs the same as the starting dose. They are listed first below because at this rung that is the whole ballgame.
| Provider | Price at 7.5 mg | Per year | Score |
|---|---|---|---|
| Coreage Rx | $199 | $2,388 | 4.5 |
| Trimi | $125 | $1,500 | 4.6 |
| PlexusDx | $189 | $2,268 | 4.4 |
| Mochi Health | $278 | $3,336 | 3.6 |
| Eden | $298 | $3,576 | 3.1 |
| Remedy Meds | $399 | $4,788 | 3.5 |
Cheapest flat-rate option at 7.5 mg: Trimi at $125 a month, which is what it charges at every other rung too.
The remaining 12 providers either price by dose or do not publish a flat-rate commitment. Their quoted figures start at $125 a month, but that is the starting-dose price — ask specifically what 7.5 mg will cost before you assume it holds.
The question to ask before you start. "What will I be charged when I reach 7.5 mg?" If the answer is not the same number you were quoted at the start, you are on a tiered programme and should budget for the higher figure rather than the advertised one.
Do you need to go higher than 7.5 mg?
Not necessarily. The ladder exists so that you can stop where the medication is working for you, and plenty of people settle below the maximum. Reaching the top dose is not a measure of success, and the trial figures are averages rather than targets.
Is 7.5 mg a real maintenance dose?
It can be, though it is studied less than 5 mg or the higher doses. If it is working for you, that is the relevant evidence. If it is not, it is designed as a stepping stone rather than a stopping point.
Compounded preparations are not FDA-approved, and approved oral GLP-1s now start around $149 — see the approved pills. Dosing belongs to your prescriber, not this page.